Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-03-01 @ 9:54 PM
Study NCT ID:
NCT01973920
Status:
COMPLETED
Last Update Posted:
2018-04-18
First Post:
2013-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study
Sponsor:
Oshadi Drug Administration
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OS-ICP-P2 -01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None